Motor and Functional Improvement in a 71-Year-Old Parkinson’s Disease Patient Following a Series of Intravenous Nanobubble and Methylene Blue Therapy: A Case Report
Case report shows significant motor function improvements in a Parkinson’s disease patient, indicating nanobubble and methylene blue therapy may enhance treatment options.
Key Points
A 71-year-old male with Parkinson's disease experienced a notable motor function improvement after therapy.
The UPDRS-III motor score dropped from 28 to 18, demonstrating a 35.71% reduction in motor difficulties.
An innovative regimen included intravenous methylene blue and nanobubble therapies alongside baseline medications.
Findings suggest potential for these treatments to serve as effective adjuncts in neurological care for Parkinson's disease.